行情

ASMB

ASMB

Assembly生物
NASDAQ

实时行情|Nasdaq Last Sale

16.42
+0.16
+0.98%
盘后: 16.42 0 0.00% 16:00 04/09 EDT
开盘
16.64
昨收
16.26
最高
16.90
最低
15.65
成交量
16.27万
成交额
--
52周最高
25.07
52周最低
8.13
市值
5.36亿
市盈率(TTM)
-4.4215
分时
5日
1月
3月
1年
5年

分析师评级

5位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测ASMB价格均价为42.50,最高价位74.00,最低价为30.00。

EPS

ASMB 新闻

更多
  • 白俄罗斯总理建议欧亚经济联盟大力推动去美元化进程
  • 央视 · 2小时前
  • 摩根大通大幅下调对美国经济前景的预期
  • 新浪财经综合 · 2小时前
  • 2.3万亿美元并非最后一搏,美联储还能继续放水!
  • 新浪财经综合 · 2小时前
  • 美股战“疫”小记:美股在这个早春都经历了什么?
  • 新浪财经综合 · 2小时前

所属板块

制药
+0.59%
制药与医学研究
+0.82%

热门股票

代码
价格
涨跌幅

ASMB 简况

Assembly Biosciences, Inc. is a biotechnology company. The Company is engaged in developing two platform programs, such as a class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection, and a class of oral synthetic live therapeutics, which are designed to restore health to a dysbiotic microbiome. It has discovered various core protein Allosteric Modulators (CpAMs), which are small molecules that directly target and allosterically modulate the HBV core (HBc) protein. Its Microbiome Program consists of an integrated platform that includes a strain identification and selection process, methods for strain isolation and growth under current good manufacturing practice conditions, and a delivery system, GEMICEL, which allows for targeted oral delivery of live biologic and conventional therapies to the lower gastrointestinal (GI) tract. The lead product candidate from this platform, AB-M101, is in development for the treatment of clostridium difficile-infections.
展开

微牛提供Assembly Biosciences Inc(NASDAQ-ASMB)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的ASMB股票新闻,以帮助您做出投资决策。